# FDA Inspection 1269495 - Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. - April 11, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/evonik-rexim-nanning-pharmaceutical-co-ltd/9f860ea2-93f5-43b3-9e73-8525d6950d86
Source feed: FDA_Inspections

> FDA Inspection 1269495 for Evonik Rexim (Nanning) Pharmaceutical Co. Ltd. on April 11, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1269495
- Company Name: Evonik Rexim (Nanning) Pharmaceutical Co. Ltd.
- Inspection Date: 2025-04-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1269495 - 2025-04-11](https://www.globalkeysolutions.net/records/fda_inspections/evonik-rexim-nanning-pharmaceutical-co-ltd/7c48315b-f6d9-4a32-91c8-355b8b0ea9ed)
- [FDA Inspection 1068951 - 2018-09-28](https://www.globalkeysolutions.net/records/fda_inspections/evonik-rexim-nanning-pharmaceutical-co-ltd/6da192bb-f430-4ee1-a8db-9626306d8e9e)
- [FDA Inspection 951232 - 2015-11-13](https://www.globalkeysolutions.net/records/fda_inspections/evonik-rexim-nanning-pharmaceutical-co-ltd/1dbb051b-31d9-4777-a1d9-0e94f6f77dbe)

Company: https://www.globalkeysolutions.net/companies/evonik-rexim-nanning-pharmaceutical-co-ltd/6324d0c3-0f41-474e-a714-d53659e1a622

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c